Group B streptococcus: early- and late-onset infections.

A. Berardi, C. Tzialla, M. Riva, R. M. Cerbo, R. Creti

Research output: Contribution to journalArticle

Abstract

Group B streptococcus has emerged as a prominent neonatal pathogen in developed countries since the late 1960s. The incidence of disease remained fairly constant until the 1990 s, when prevention efforts increased. American consensus guidelines were endorsed in the mid 1990 s; since then a decrease in disease incidence has been reported in the United States. This review summarizes the main issues regarding the prevention of neonatal infection and presents aspects of group B streptococcal disease with the first population data recently obtained in a northern region of Italy.

Original languageEnglish
Pages (from-to)24-27
Number of pages4
JournalJournal of Chemotherapy
Volume19 Suppl 2
Publication statusPublished - Oct 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Group B streptococcus: early- and late-onset infections.'. Together they form a unique fingerprint.

  • Cite this